MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Clinical trials for MALIGNANT PERIPHERAL NERVE SHEATH TUMORS explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT PERIPHERAL NERVE SHEATH TUMORS trials appear
Sign up with your email to follow new studies for MALIGNANT PERIPHERAL NERVE SHEATH TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancers: testing a promising drug
Disease control Recruiting nowThis study is testing whether the drug selinexor can help control certain childhood solid tumors that have come back or have not responded to standard treatments. It is for children as young as 1 year old who have specific cancers like Wilms tumor, rhabdoid tumor, or MPNST, and w…
Matched conditions: MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for kids with tough cancers: first trial of a novel cell therapy
Disease control Recruiting nowThis is a first-in-human study testing a new type of personalized cell therapy for children and young adults (up to age 21) whose solid tumors have come back or haven't responded to standard treatments. Doctors will collect a patient's own immune cells (T cells), genetically modi…
Matched conditions: MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New pill targets genetic weakness in Tough-to-Treat cancers
Disease control Recruiting nowThis is the first study in people of an experimental pill called MRTX1719. It is for adults with advanced solid tumors that have a specific missing gene called MTAP, which is found in some lung cancers, mesothelioma, and other cancers. The main goals are to find a safe dose, see …
Matched conditions: MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Simple blood test could spot dangerous nerve tumors sooner
Diagnosis Recruiting nowThis study is testing whether a 'liquid biopsy'—a simple blood test—can detect a dangerous type of nerve tumor (MPNST) earlier than current methods in adults with Neurofibromatosis Type 1 (NF1). Researchers will follow 1,000 adults with NF1 for five years, collecting blood sample…
Matched conditions: MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Sponsor: David Miller • Aim: Diagnosis
Last updated Mar 31, 2026 12:11 UTC
-
Worldwide hunt for clues in rare nerve cancer
Knowledge-focused Recruiting nowThis study is creating a worldwide database to collect detailed information about a rare and aggressive type of nerve cancer called Malignant Peripheral Nerve Sheath Tumor (MPNST). It aims to gather past and future patient data, including tumor samples and treatment history, to u…
Matched conditions: MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:18 UTC